Trial Profile
An Open-Label, Safety and Tolerability, Study Evaluating KNS-760704 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2021
Price :
$35
*
At a glance
- Drugs Dexpramipexole (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Sponsors Knopp Biosciences
- 20 Dec 2017 New trial record